Have an "Exit Plan" for Antipsychotics in Dementia Patients
Growing interest in Nuedexta (dextromethorphan/quinidine) will raise questions about how to treat agitation or psychosis in dementia patients.
About one in 6 nursing home residents take an antipsychotic.
But benefits are small at best. Plus, there's one more death for every 50 to 100 dementia patients on an atypical for 8 to 12 weeks.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote